Atomera Incorporated vs Bio-Rad Laboratories, Inc. Class A Common Stock — how do they compare? Atomera Incorporated trades at $6.48 (market cap $241.98M), while Bio-Rad Laboratories, Inc. Class A Common Stock trades at $298.3 (market cap $8.02B). The key difference: Bio-Rad Laboratories, Inc. Class A Common Stock is far larger — about 33.1× Atomera Incorporated's market cap, and Bio-Rad Laboratories, Inc. Class A Common Stock is trading nearer its 52-week high, Atomera Incorporated nearer its low. Which is the better fit depends on your goals.
| ATOM | BIO | |
|---|---|---|
Market Cap | $241.98M | $8.02B |
Sector | Technology | Health |
52-Week High | $12.11 | $339.75 |
52-Week Low | $1.99 | $241.71 |
Enterprise Value | $202.19M | $7.84B |
Trailing returns across standard periods
Atomera is a semiconductor materials engineering company. Its Mears Silicon Technology (MST) is a patented thin film that enhances transistor performance, power efficiency, and cost for global chip manufacturers.
Read more on ATOM →Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →